Abstract
Hydrogen peroxide (H2O2) is a main second messenger in oncogenic signaling networks including the Ras and the growth factor receptor pathways. This is achieved predominantly through the oxidation of redox-sensitive cysteine (Cys) residues in proteins resulting in changes to their structure and function. We previously identified annexin A2 (ANXA2) as a redox regulatory protein that plays an important cellular role during oxidative stress and also promoting tumorigenesis. Here we investigated the role of ANXA2 in the regulation of H2O2-dependent signaling that drives tumor progression. We show that depletion of ANXA2 leads to the enhanced activation of AKT following either EGF/EGFR stimulation or oncogenic Ras transformation. The phosphatase and tensin homologue (PTEN) protein negatively regulates the PI3K/AKT pathway. We demonstrate that ANXA2 via its reactive Cys-8 residue, binds to PTEN and that the co-expression of PTEN and ANXA2, but not ANXA2 Cys-8-Ala mutant, inhibits AKT phosphorylation on Ser 473. These results indicate that ANXA2 is important for PTEN regulation within the PI3K/AKT signaling cascade. Furthermore, we also reveal that ANXA2 inversely regulates the expression of the peroxidase, peroxiredoxin 2, in a reactive oxygen species dependent manner.
Original language | English |
---|---|
Article number | 492 |
Journal | Cancers |
Volume | 11 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2019 |
Bibliographical note
Funding Information:Funding: P.A.M. is funded by FCT Investigator contract from the Foundation for Science and Technology (FCT), Portugal (ref:IF/00614/2014) and FCT exploratory grant, ref:IF/00614/2014/CP12340006. CBMR is financed by FCT Research Center Grant ref:UID/BIM/04773/2013CBMR1334. S.A.C. was recipient of FCT research fellowship (ref: WELCOMEII/57/UALG/1050/2011). T.A. was recipient of ERASMUS Mundus fellowship (EMQAL), ref: FPAnr2013-0225. A.H. is sponsored (and grateful to) the Ollie Young Foundation, charity number 1148511. R.H. is funded by Brain Tumour Research.
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
ASJC Scopus Subject Areas
- Oncology
- Cancer Research
PubMed: MeSH publication types
- Journal Article